DeepMed Research

WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Single-arm, Phase II Clinical Trial of ASPIRin to PrEvent Venous Thromboembolism in Patients with Advanced Germ Cell Tumors Receiving Chemotherapy

Phase 2

Not yet recruiting

Conditions: Germ Cell Tumor
Testicular Cancer

Interventions: Drug: Low-dose ASA

First Posted Date: 2025-03-10

Last Posted Date: 2025-03-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 35

Registration Number: NCT06866964

Locations: 🇺🇸
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte, North Carolina, United States
🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

GLP-1s to Enhance Lasting Optimal Weight

Phase 4

Not yet recruiting

Conditions: Obesity

Interventions: Drug: Tirzepatide

First Posted Date: 2025-03-06

Last Posted Date: 2025-03-06

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 40

Registration Number: NCT06861439

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass

Not Applicable

Not yet recruiting

Conditions: Glucose Metabolism Disorders (Including Diabetes Mellitus)

First Posted Date: 2025-03-06

Last Posted Date: 2025-04-24

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 100

Registration Number: NCT06861881

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Intrathecal Amniotic Fluid Stem Cells for Progressive Multiple Sclerosis

Phase 1

Not yet recruiting

Conditions: Multiple Sclerosis, Progressive

Interventions: Biological: Amniotic fluid or placental CD117 stem cells

First Posted Date: 2025-02-24

Last Posted Date: 2025-03-17

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT06841068

Locations: 🇺🇸
Atrium Health, Charlotte, North Carolina, United States

Super-Supporters - Virtual Care Technology Navigators

Not Applicable

Completed

Conditions: Telemedicine

First Posted Date: 2025-02-24

Last Posted Date: 2025-03-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1111

Registration Number: NCT06841081

Locations: 🇺🇸
Atrium Health, Charlotte, North Carolina, United States
🇺🇸
Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States

Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors

Phase 4

Not yet recruiting

Conditions: Fatigue

Interventions: Drug: Fisetin followed by Placebo
Drug: Placebo followed by Fisetin

First Posted Date: 2025-02-11

Last Posted Date: 2025-02-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT06819254

Locations: 🇺🇸
Atrium Health Wake Forest Baptist Hospital, Winston-Salem, North Carolina, United States

Project neuroARTEMIS

Not Applicable

Recruiting

Conditions: Stimulant Use
Human Immunodeficiency Virus (HIV)
Depression

First Posted Date: 2025-02-07

Last Posted Date: 2025-05-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 189

Registration Number: NCT06814275

Locations: 🇺🇸
Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States

RCT-Consumer Perceptions of Cannabidiol (CBD) Health Claims

Not Applicable

Recruiting

Conditions: Prevention

First Posted Date: 2025-01-29

Last Posted Date: 2025-02-12

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 420

Registration Number: NCT06800066

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Discharge Medication Use Post-Operatively in GU Cancer Patients

Recruiting

Conditions: Genitourinary Cancer

First Posted Date: 2025-01-27

Last Posted Date: 2025-02-25

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 684

Registration Number: NCT06795087

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke

Phase 2

Not yet recruiting

Conditions: Acute Ischemic Stroke

Interventions: Drug: Intra-arterial Tenecteplase
Drug: Intra-arterial Saline

First Posted Date: 2025-01-17

Last Posted Date: 2025-03-18

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 40

Registration Number: NCT06781385

Locations: 🇺🇸
Atrium Health Neurosciences Institute, Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy